Abstract Background: Variceal hemorrhage (VH) is a major complication of chronic liver disease. Several factors have been validated for the prediction of the outcome of an acute VH. The clinical risk characteristics reported in developed countries may be different from developing countries. Aim: The aim of this study was to determine the predictors of mortality in patients admitted to our hospital with acute upper gastrointestinal (UGI) hemorrhage who underwent endoscopy and confirmed to have VH. Patients and methods: This was a cross sectional hospital based study performed over a seven-year period between January 2006 and January 2013. Results: A total of 224 patients were analyzed. Nineteen patients (8%) died within the first two weeks of their hospital admission. Eighteen variables were studied and included in a multivariate analysis using a logistic regression model. Five variables were predictors of death. Hemodynamic instability at admission (AOR = 5.5, 95% CI = 22.3 + 1.4, P = 0.017), Child class C (AOR = 5.9, 95% CI = 24 + 1.5, P = 0.013), blood in upper gastrointestinal (UGI) tract at the index endoscopy (AOR = 12.8, 95% CI = 126.5 + 1.3, P = 0.03), rebleeding within five days of endoscopy (AOR = 25.4, 95% CI = 109.2 + 5.9, P = 0.000), and in-hospital complications (AOR = 23.4, 95% CI = 122.5 + 4.5, P = 0.000) were independent predictors of mortality after the acute VH episode. Conclusion: Patients with acute VH and hemodynamic instability at admission, Child class C, blood in UGI tract at the index endoscopy, rebleeding within five days of endoscopy and in-hospital complications are at an increased risk of mortality after the acute VH episode. Rebleeding within five days of endoscopy and in-hospital complications are the most significant independent predictors of mortality.
Introduction
Variceal hemorrhage (VH) is a major complication of chronic liver disease and is associated with significant morbidity and mortality. 1, 2 Although overall survival may be improving over the past 40 years, mortality is still closely related to failure to control bleeding or early rebleeding and this is not uncommon during the first days to 6 weeks after admission. [2] [3] [4] [5] A variety of clinical risk characteristics have been adopted to assist with patient assessment and a number of them have been applied for use in prognostic scoring algorithms (e.g. Rockall score). These are used to evaluate risk of death and/ or re-bleeding in upper gastrointestinal (UGI) hemorrhage patients, and also to screen for and to select high risk patients for intervention within an appropriate time. Several factors have been specifically validated for the prediction of the outcome of acute VH. 5, 6 Prognostic factors of mortality in acute VH included presentation with hematemesis, failure to control bleeding within five days, raised bilirubin, presence of ascites, encephalopathy, shorter interval to admission to hospital, plasma urea, bleeding starting in hospital, prothrombin time <40%, recent use of steroid drugs within seven days of bleeding, age > 60 years, hepatic venous pressure gradient, concomitant hepatocellular cancer and transfusion need. 6 The clinical risk characteristics reported in developed countries may be different from those in developing countries.
Egypt has a large burden of chronic liver disease. Schistosomiasis and hepatitis C virus are common diseases in Egypt. The overall prevalence positive for antibody to hepatitis C virus was 14.7%. 7 Despite the advent of endoscopy and endoscopic therapy, access to medical centers with experienced medical staff and adequate equipment in Egypt is still limited. Most government hospitals refer patients with acute UGI hemorrhage to teaching hospitals, academic institutes, insurance hospitals and private hospitals. Many patients never reach hospital. A plan for management of UGI hemorrhage was designed in a governmental hospital to be within the available resources and was formulated in two stages. Stage one, 2000 Stage one, -2004 , was the training of staff and preparation. During this time we assessed the capability of the hospital for dealing with these cases. Following the assessment we went to stage two. Stage two started in 2004 and all patients presenting with acute UGI hemorrhage have been assessed and managed in house. [8] [9] [10] The aim of this study was to determine the predictors of mortality in patients admitted to our hospital with acute UGI hemorrhage who underwent endoscopy and confirmed to have VH.
Patients and methods
This was a cross sectional hospital based study. The study was performed in a secondary-care governmental hospital (Bolak Eldakror Hospital, Giza, Egypt) on cirrhotic patients presenting with acute UGI hemorrhage who underwent endoscopy and confirmed to have VH over a seven-year period between January 2006 and January 2013.
A management plan for acute UGI hemorrhage composed of five steps (assessment, resuscitation, diagnosis, stoppage of bleeding and prevention of rebleeding) was designed. A management protocol, based on international standards, was established with the intention of improving the quality and efficiency of our health care delivery (Table 1) . 11, 12 Clinical guidelines and a clinical care pathway were developed within the availability of local therapeutic options in order to provide a stand-alone practical guide for the team (Table 1 ). The care pathway was developed to improve patient management and resource utilization. The guidelines and care pathway were disseminated to house officers, residents, physicians, and nursing staff. This was accomplished via medical rounds and conferences for the medical staff. Printed sheets were posted in the emergency room, intensive care and medical department that outlined the care pathway. A consultant gastroenterologist was on-call 24/7 days a week to attend resuscitation when bleeding was detected. The gastroenterologist served as a facilitator for the medical staff caring for the patients, often monitoring intravenous hydration and delivering blood/blood products.
Stratification of patients in low and high-risk categories for rebleeding and mortality was performed using the Rockall score. Patients with a low risk were discharged home and subsequently underwent diagnostic endoscopy on the next available list. Those at high risk were admitted to hospital for intensive monitoring and early, energetic resuscitation. Endoscopy was performed on the morning of the second day to establish diagnosis, to control bleeding and to prevent rebleeding if considered appropriate. All patients presenting with acute UGI hemorrhage and a confirmed diagnosis of liver cirrhosis were admitted, assessed and resuscitated in a three-bed intensive-care unit. Liver cirrhosis was diagnosed on the basis of clinical and laboratory data and ultrasonography. Child classification was used to assess hepato-cellular function in Primary: GV that can be detected at the first endoscopy Secondary: GV that occur within two years of eradication of EV Types of gastric varices Gastro-esophageal varices (GEV) types 1 and 2: those GV that are continuous with EV and occur along the lesser curvature or the fundus, respectively Isolated gastric varices types 1 and 2 (IGV): those GV that are discontinuous from the EV and occur either in the fundus of the stomach or anywhere else in the stomach, including the body, antrum, pylorus, and duodenum, respectively. GV can occur in the absence of EV or in the presence of only grade I EV Control of acute variceal hemorrhage -Esophageal varices Band ligation is the method of first choice If banding is difficult because of continued bleeding sclerotherapy should be performed Injection sclerotherapy with ethanolamine oleate is first choice and if failure to control bleeding histoacryl can be used -Gastric varices Baveno IV consensus: Treat all GV with histoacryl BSG guidelines 2000: Treat GEV as for EV and IGV with histoacryl Secondary prophylaxis of variceal hemorrhage -Non-selective beta blockers with or without endoscopic therapy -Esophageal varices Band ligation after 4-10 days, then every 2-4 weeks until eradication then every 3-6 months. Single band to each varix Sclerotherapy to other small vessels and to complete eradication -Gastric varices
A repeat session for GEV should be done after one week (unless there is diffuse ulcers) and on weekly basis. IGV usually requires one or two sessions for obliteration Injection of sclerosant -Injection sclerotherapy of EV using ethanolamine oleate Use 23-gauge sclerotherapy needle Intravariceal or perivariceal injection 2-4 ml is injected into a single EV During active bleeding start injection below the site of bleeding During follow up start injection at Z line -Injection sclerotherapy of GV using histoacryl All attendants should use goggles during the procedure Use 21-gauge sclerotherapy needle with 6-8 mm long needle tip Prepare a mixture of 0.5 ml of histoacryl with 0.7 ml of lipiodol Use 5 ml syringe and inject 1.2-4.6 ml in of this mixture into single GV All GV must be injected at the same time and should be Intravariceal For better view of the fundus especially with IGV1 or GOV2: the patient in the prone or right lateral position, head end of the patient raised to 30-45 degree and injection is performed by retroflexion the endoscope To avoid injury of endoscope channel: before retroflexion push the injector outside the tip for 1 cm To fix the tip of the endoscope in front of fundal varices: after retroflexion of the endoscope, lock the right-left knob Precautions for preventing endoscope channel and injector blockage: apply lipiodol at the tip of the endoscopic channel, avoid suction during injection of the glue, water irrigation after injection of the glue and do not pull the injector out through the endoscopic channel until the injector is properly cleaned from any adherent material cirrhosis. Every patient was assigned a class based on the presence of ascites, neurological disorder, nutritional status, serum bilirubin and albumin levels. Histological examination of the liver was not performed. The etiology of the liver disease was not determined in any patient. Those who were hemodynamically unstable (heart rate > 100 beats/minute, hypotension with a systolic pressure < 90 mmHg and/or diastolic value < 60 mmHg) were managed with crystalloid solutions with or without blood transfusion. Patients with hemoglobin less than 7 g/dl were transfused according to individual requirements. All patients suspected to have VH received prophylactic antibiotic therapy (IV third generation cephalosporin). Endoscopy was performed on the morning of the second day to establish the diagnosis, to control bleeding and prevent rebleeding. All patients received conscious sedation. IV midazolam (2.5 mg) was the agent used. All endoscopies were performed by two well-trained experienced endoscopists. All patients with VH received initial endoscopic therapy (sclerotherapy, band ligation or both). If hemostatic therapy was unsuccessful, either because bleeding was not controlled or rebleeding occurred, repeat endoscopy was considered. Balloon tamponade, vasoactive drugs, surgical shunts and trans-jugular intrahepatic porto-systemic shunts were not locally available. Patients were observed in the medical department for a minimum of five days before discharge. During the study period 500 patients with concomitant acute UGI hemorrhage and liver cirrhosis were admitted. One hundred and forty-two patients (28%) did not undergo an inpatient endoscopy for various reasons and 358 patients (72%) underwent endoscopy (Tables 2 and 3) . Patients who did not undergo inpatient endoscopy and those who had non variceal hemorrhage were excluded.
Two hundred and twenty-four patients with concomitant acute UGI hemorrhage and liver cirrhosis who underwent endoscopy and confirmed to have VH were included in the analysis. A standardized data collection form (sheet) was completed for each patient. Recorded data included demographic information and historical data: smoking history, drugs used (aspirin, non-steroidal anti-inflammatory drugs and anticoagulants), alcohol consumption, patient condition at the time of bleeding, presenting symptoms and co-morbid illnesses. Physical and laboratory examination findings included 
Epinephrine injection and thermal electrocoagulation Epinephrine is diluted (1:10,000) and administered through a 23-gauge sclerotherapy needle. 2 ml can be given in increments targeting four quadrants of the ulcer. Larger volumes (35-45 ml) were more effective in providing hemostasis as compared to standard volumes (15-25 ml) though there are no clear guidelines as to the ideal volume required Thermal (bipolar) electrocoagulation: The probe, of Boston Scientific Corp., is forcefully opposed directly on the major stigmata of hemorrhage and pulse treatment of 5-10 s with a power of 10-15 W are applied followed by water irrigation until target coagulation is achieved Follow up after endoscopic therapy IV proton pump inhibitors for 48 h then continue with ordinary dose Hemostasis after first endoscpoic therapy is usually achieved in more than 94% of procedures when thermocoagulation of bleeding lesions is used After bleeding from ulcers is controlled endoscopically the rate of recurrent bleeding is 15 to 20% The minority of patients in whom hemostasis is not achieved by an initial endoscopic therapy or rebleeding occurs at least one more endoscopic therapy is preferable to surgery Indications of surgery Failure of endoscopic therapy: common in posterior wall duodenal ulcers or large ulcer Active severe bleeding during endoscopy Types of surgery -According to patient's condition, competence and preference of the surgeon -Conservative surgery (minimal surgery) Underrunning of the bleeding vessel or ulcer excision Followed by H2 antagonist -Conventional surgery (ulcer-curing surgery)
Vagotomy and gastrectomy or vagotomy and pyloroplasty hemodynamic data, initial hemoglobin level, resuscitative efforts (blood transfusion requirement), Child status and Rockall score. The endoscopic components of the database included identification of the time to endoscopy, bleeding lesion and endoscopic therapy. Outcome measures were rebleeding within five days of endoscopy, complications (organ failure), the need for intervention (re-endoscopy, endoscopic therapy) and mortality. The cause of death and the time interval (in hours) between endoscopy and death was determined. In patients with multiple admissions for acute VH, each admission was treated separately. In case of death in the second or subsequent admission, the patient's data were analyzed as 'survivor' in the initial admission(s) and as 'deceased' in the last admission. The relationship between various clinical parameters at admission to mortality was assessed. The parameters were: gender, age, patient condition at the time of bleeding, presence of ascites, hepatocellular carcinoma, other comorbidity, Child class, presenting symptom, hemodynamic status, hemoglobin level, transfusion need, time to endoscopy, blood in UGI tract at the index endoscopy, source of bleeding, endoscopic therapy, Rockall risk score, rebleeding within five days of endoscopy and in-hospital complications. Univariate and multivariate analyses were performed on the data. Eighteen variables were studied and included in a multivariate analysis using a logistic regression model.
Statistical analysis
The data were registered, tabulated and analyzed statistically using a program of SPSS version 15. Data on quantitative variables are presented as mean and (SD), and numbers and percentages are reported for qualitative variables. Differences between the proportion of survivors and deceased were assessed by using chi-squared. Variables with a P value of <0.05 on univariate analysis were included in step-wise multiple logistic regression analysis to identify independent risk factors for mortality. Wald statistics was used to assess the importance of each variable in the model, with P values <0.05 taken as significant.
Results
A total of 224 patients were analyzed. Sixty-three percent were male and 37% female. Ages ranged from 20 to 87 years, mean 53 ± 10 years. One hundred and sixty-three patients (73%) aged <60 years. Sixty-five patients (29%) had a history of smoking. Seventy-one patients (32%) were taking aspirin or non-steroidal anti-inflammatory drugs and two (1%) anticoagulants. Three patients (1%) were consuming alcohol. Two hundred and twelve patients (95%) were emergency admissions and 12 (5%) were inpatients at the time of bleeding. Cirrhosis was newly diagnosed during hospitalization for VH in 22 patients (10%) and had been previously diagnosed in 202 (90%). The presenting symptoms were hematemesis in 139 patients (62%), melena in 27 (12%) and both in 58 (26%). One hundred and eighty-five patients (83%) were hemodynamically stable at admission and 39 (17%) were hemodynamically unstable. Ninety patients (40%) had cirrhosis alone and 134 (60%) had cirrhosis and ascites. Thirty-three patients (15%) had concomitant hepatocellular carcinoma. Forty-nine patients (22%) were Child class A, 78 (35%) class B and 97 (43%) class C. Co-morbidities other than liver cirrhosis are shown in Table 4 . The mean hemoglobin concentration was 8 ± 2 g/dl and 44% had initial hemoglobin less than 7 g/dl. One hundred and fifty-four patients (69%) required blood transfusion and the average number of transfused blood units was three.
All patients underwent emergency endoscopy during admission. The mean time from presentation to endoscopy was 23 ± 22 h (30 min-168 h). Endoscopy was conducted within 24 h of presentation in 170 patients (76%). Endoscopy was delayed more than 24 h in 54 patients (24%). The most common reasons for delay were unavailable staff or equipment in 28 patients, admission during weekends or holidays in 17, hemodynamic instability in five and medical condition (chronic obstructive pulmonary disease with respiratory distress and asthma) in four. One hundred and seventy-seven patients (79%) bled from esophageal varices and 47 (21%) from gastric varices. Blood in UGI tract was detected at the index endoscopy in 132 patients (59%). The mean full Rockall score was five and 101 patients (45%) had Rockall score six to eight. All patients received endoscopic therapy at the time of initial endoscopy. Injection sclerotherapy was performed in 123 patients (55%), band ligation in 94 (42%) and both in seven (3%). Injection sclerotherapy with ethanolamine oleate solution was used to treat 82 patients (37%), tissue adhesive (histoacryl) in 32 (14%) and both in 16 (7%). Initial hemostasis was achieved in 201 patients (90%) and 23 (10%) had rebleeding during the same admission. Seventeen patients (8%) had therapy at a subsequent endoscopy for further bleeding. Complications were reported in 25 patients (11%) during the same hospitalization. The most frequent complications were encephalopathy (5%), ascites (5%) and acute myocardial infarction (1%). Two hundred and five patients (92%) were discharged improved and 19 (8%) died within the first two weeks of their hospital admission. The time interval from endoscopy to death ranged from 15 min to 288 h, mean 42 ± 70 h. Death was caused by continuing bleeding in 11 patients (5%), associated complications (mainly organ failure) in four (2%), co-morbid disease (cardiac arrest) in two (1%) and endoscopy was considered a possible cause (sedation related complications in patients with major co-morbidity) in two (1%). Univariate and multivariate analyses of variables in relation to mortality are shown in Tables 5 and 6 .
Discussion
VH is a major complication of cirrhosis and portal hypertension, and is responsible for considerable morbidity and mortality. In recent years, improvements in patient management, including the use of terlipressin, prophylactic antibiotics, variceal band ligation and trans-jugular intrahepatic portosystemic shunts, have resulted in a decline in in-hospital mortality. [13] [14] [15] [16] [17] Though the mortality rate has decreased with advances in the management of VH, it continues to be unacceptably high. 17 Mortality in acute VH has decreased to current levels by only approximately 20%. 18 One of the most challenging topics for physicians in their approach to the management of cirrhosis is the evaluation of their patients' prognosis. Those with cirrhosis who have VH are at a substantially higher risk of mortality so the identification of factors that influence prognosis should be helpful in planning their management. The factors that predict prognosis however vary between studies. 17 One of the difficulties with predicting prognosis is that outcome is influenced not only by the severity of the bleeding episode itself, but also by the severity of the underlying liver disease. 18 Currently, there is no well-established model for the accurate prediction of survival in patients with cirrhosis following an episode of acute VH. 18 The aim of this study was to determine the predictors of mortality in patients admitted to our hospital with acute UGI hemorrhage who underwent endoscopy and confirmed to have VH.
Our in-hospital mortality rate of 8% is consistent with the experience of other centers. Studies reported that in-hospital mortality in cirrhotic patients admitted with acute VH ranged from 7.4% to 14.2%. 17, 19, 20 However, in other studies, the rate of mortality was at least 20% at 6 week in patients with acute VH. 3, 21 During the study period, 9% of cirrhotic patients admitted to our hospital with acute UGI hemorrhage died rapidly after admission without having undergone an endoscopy due to continued bleeding or rebleeding. Endoscopy was performed on the morning of the second day and not on admission, so patients who died before performing the endoscopy were not included in the analysis. The mean time from admission to death was six hours (range 25 min-18 h). The future plan is to perform endoscopy as soon as the patients have been resuscitated.
Univariate and multivariate analyses of variables in relation to mortality were performed. Eighteen variables were studied and included in the analysis. Five variables were independent predictors of death: the hemodynamic instability at admission, Child class C, blood in UGI tract at the index endoscopy, rebleeding within five days of endoscopy, and inhospital complications. Rebleeding within five days of endoscopy and in-hospital complications were the most significant.
Mortality was related to the severity of bleeding episode as expressed by hemodynamic instability at admission and presence of blood in UGI tract at the index endoscopy. Our results are in line with previously published data. 17, 22, 23 Energetic resuscitation and early endoscopy might improve the prognosis of these patients. Mortality was related to the severity of liver dysfunction as expressed by Child classification. The effectiveness of Child classification as a predictor of in-hospital death in cirrhotic patients with acute VH proved to be similar to that reported in other studies. [22] [23] [24] [25] The different statuses of liver cirrhosis had different prognosis in terms of progression toward death. This might help inform patients of the risks of potential outcomes.
Mortality was related to the occurrence of rebleeding within five days of endoscopy and in-hospital complication. Our results are in line with previously published data. 17, 22, 24 In hospital rebleeding and complications played a highly significant role for stratification of patients with high mortality. Both occurred after admission which indicates that prognosis may change from day to day. This necessitates intensive monitoring of cirrhotic patients with acute VH during hospitalization and further improvement to control bleeding might still improve the prognosis of these patients.
Mortality was high in patients with a high risk Rockall score. Surprisingly, patients with a high Rockall score had a higher risk of mortality in univariate analysis while the risk of mortality was not significant in multivariate analysis. A high Rockall score was not an independent risk of mortality in our patients. The Rockall risk assessment score was devised to allow prediction of the risk of rebleeding and death in patients with UGI hemorrhage. 26 Only 4.4% of patients included in the initial study had esophageal varices, and analysis was not performed according to the etiology of bleeding. 27 The objective of the Rockall score was to predict patient poor clinical outcomes. It was also validated in many other settings, but with diverse conclusions. 26 Some authors reported good prediction for re-bleeding, but poor prediction for death while the others reported the opposite directions. 26 Endoscopic therapy applied was effective in controlling VH in 90% of patients. It was reported that endoscopic therapy was effective in controlling VH in 84% and 90% of patients in two studies. 18, 25 Mortality was high when endoscopic therapy applied was injection sclerotherapy. Injection sclerotherapy was commonly performed in patients with severe hemorrhage. Hemodynamic instability at admission and blood in UGI tract at the index endoscopy were significantly associated with the injection sclerotherapy. The risk of mortality with injection sclerotherapy was significant in univariate analysis and not significant in multivariate analysis. Endoscopic therapy applied was not an independent risk of mortality.
Eleven variables were not predictive of mortality: gender, age > 60 years, inpatients at the time of bleeding, presence of ascites, concomitant hepatocellular carcinoma, other comorbidity, presentation with hematemesis, initial hemoglobin less than 7 g/dl, transfusion need, delay to endoscopy more than 24 h and source of bleeding. Most of these risk factors were identified as predictors of mortality from acute VH in published studies. 5, 6, 21 The clinically and statistically important factors detected from this study allow for early identification of patients with acute VH who are at a substantially increased risk of death over the short term in Egypt. These patients may require care in more specialized units during the bleeding episode, intensive monitoring, energetic resuscitation, early endoscopy, various options to control bleeding and aggressive follow-up in the immediate post-variceal bleed setting. Our hospital, like most governmental hospitals in Egypt, has limited resources so our findings can be generalized to the broader community. Limitations of this study: etiology of the underlying liver disease, laboratory parameters and variceal size were not assessed. Additionally, the initial version of Child classification, which includes a subjective criterion (nutritional status), was used. Some patients whose individual values fall into different groups could not be properly categorized in this version. The study was not designed to collect the parameters necessary for the accurate calculation of the Child-Pugh score.
Conclusion
This study demonstrates that the hemodynamic instability at admission, Child class C, blood in UGI tract at the index endoscopy, rebleeding within five days of endoscopy and inhospital complications were independent predictors of mortality after the acute VH episode with rebleeding within five days of endoscopy and in-hospital complications being the most significant. This study may guide clinicians to pay particular attention to patients with these risks. For future implications, these risk characteristics may be used in the process of VH risk stratification.
